Contemporary concepts in the evaluation and management of male infertility

Nature Reviews Urology

Volumn 8, Issue 2, 2011, Pages 86-94

  Hwang, Kathleen ^a   Walters, R Chanc ^a   Lipshultz, Larry I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANDROGEN; AROMATASE INHIBITOR; ASCORBIC ACID; BROMOCRIPTINE; CABERGOLINE; CAROTENOID; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; COPPER; ENCLOMIFENE; FOLLITROPIN; GLUTATHIONE; GONADORELIN; LUTEINIZING HORMONE; OXYTOCIN; PROLACTIN; REACTIVE OXYGEN METABOLITE; SELENIUM; SEX HORMONE BINDING GLOBULIN; SPERM ANTIBODY; TAMOXIFEN; TESTOSTERONE; THYROTROPIN; UBIDECARENONE; ZINC;

ACROSOME; ANDROGEN DEFICIENCY; AZOOSPERMIA; CELL ASSAY; CELL VIABILITY; CLINICAL EVALUATION; CONCEPTION; DISEASE ASSOCIATION; DNA DAMAGE; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC SCREENING; HORMONAL THERAPY; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOOSMOTIC STRESS; INFERTILITY; KARYOTYPE; LEUKOCYTE; MALE INFERTILITY; OLIGOSPERMIA; PHYSICAL EXAMINATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; SEMEN ANALYSIS; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; SPERMATOZOON PENETRATION; TESTOSTERONE BLOOD LEVEL; VARICOCELE; VAS DEFERENS; Y CHROMOSOME;

ANIMALS; DISEASE MANAGEMENT; HUMANS; INFERTILITY, MALE; MALE;

EID: 79951508691     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.230     Document Type: Review

References (97)

1. Thonneau, P. et al. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum. Reprod. 6, 811-816 (1991).
2. US Department of Health and Human Services Fertility, Contraception, and Fatherhood: Data on Men andWomen From Cycle 6 (2002) of the National Survey of Family Growth [online], http://www.cdc.gov/nchs/data/series/sr-23/sr23-026.pdf (2010).
3. Kolettis, P. N. & Sabanegh, E. S. Significant medical pathology discovered during a male infertility evaluation. J. Urol. 166, 178-180 (2001) (Pubitemid 32565374)
4. rd, Matschke, H. M. & Lipshultz, L. I. Male factor infertility. Endocrinol. Metab. Clin. North Am. 32, 689-707 (2003). (Pubitemid 37187070)
5. Sigman, M. & Jarow, J. P. Endocrine evaluation of infertile men. Urology 50, 659-664 (1997). (Pubitemid 27494982)
6. McLachlan, R. I. et al. Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. J. Androl. 23, 149-162 (2002). (Pubitemid 34169269)
7. American Urological Association. The optimal evaluation of the infertile male [online], http://www.auanet.org/content/media/optimalevaluation2010.pdf (2010).
8. Carlsen, E., Petersen, J. H., Andersson, A. M. & Skakkebaek, N. E. Effects of ejaculatory frequency and season on variations in semen quality. Fertil. Steril. 82, 358-366 (2004). (Pubitemid 39092035)
9. Wolff, H. The biologic significance of white blood cells in semen. Fertil. Steril. 63, 1143-1157 (1995).
10. Keck, C., Gerber-Schafer, C., Clad, A., Wilhelm, C. & Breckwoldt, M. Seminal tract infections: impact on male fertility and treatment options. Hum. Reprod. Update 4, 891-903 (1998). (Pubitemid 29082477)
11. Cooper, T. G. et al. World Health Organization reference values for human semen characteristics. Hum. Reprod. Update 16, 231-245 (2010).
12. th edn. (Cambridge University Press, 2010).
13. th edn. (Cambridge University Press, 1999).
14. Bostofte, E., Bagger, P., Michael, A. & Stakemann, G. Fertility prognosis for infertile men: results of follow-up study of semen analysis in infertile men from two different populations evaluated by the Cox regression model. Fertil. Steril. 54, 1100-1106 (1990).
15. Menkveld, R., Rhemrev, J. P., Franken, D. R., Vermeiden, J. P. & Kruger, T. F. Acrosomal morphology as a novel criterion for male fertility diagnosis: relation with acrosin activity, morphology (strict criteria), and fertilization in vitro. Fertil. Steril. 65, 637-644 (1996). (Pubitemid 26069124)
16. Celik-Ozenci, C. et al. Sperm selection for ICSI: shape properties do not predict the absence or presence of numerical chromosomal aberrations. Hum. Reprod. 19, 2052-2059 (2004). (Pubitemid 39236472)
17. Ryu, H. M. et al. Increased chromosome X, Y, and 18 nondisjunction in sperm from infertile patients that were identified as normal by strict morphology: implication for intracytoplasmic sperm injection. Fertil. Steril. 76, 879-883 (2001).
18. Saleh, R. A. et al. Leukocytospermia is associated with increased reactive oxygen species production by human spermatozoa. Fertil. Steril. 78, 1215-1224 (2002). (Pubitemid 35463118)
19. Rasanen, M. L., Hovatta, O. L., Penttila, I. M. & Agrawal, Y. P. Detection and quantitation of sperm-bound antibodies by flow cytometry of human semen. J. Androl. 13, 55-64 (1992).
20. Endtz, A. W. A rapid staining method for differentiating granulocytes from "germinal cells" in Papanicolaou-stained semen. Acta Cytol. 18, 2-7 (1974).
21. Tremellen, K. Oxidative stress and male infertility-a clinical perspective. Hum. Reprod. Update 14, 243-258 (2008). (Pubitemid 351566975)
22. Iwasaki, A. & Gagnon, C. Formation of reactive oxygen species in spermatozoa of infertile patients. Fertil. Steril. 57, 409-416 (1992).
23. Aitken, R. J., Irvine, D. S. & Wu, F. C. Prospective analysis of sperm-oocyte fusion and reactive oxygen species generation as criteria for the diagnosis of infertility. Am. J. Obstet. Gynecol. 164, 542-551 (1991).
24. Aitken, R. J., Buckingham, D. W., West, K. & Brindle, J. On the use of paramagnetic beads and ferrofluids to assess and eliminate the leukocytic contribution to oxygen radical generation by human sperm suspensions. Am. J. Reprod. Immunol. 35, 541-551 (1996). (Pubitemid 26172354)
25. Aitken, R. J. & Clarkson, J. S. Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. J. Reprod. Fertil. 81, 459-469 (1987). (Pubitemid 17160425)
26. Spano, M. et al. Sperm chromatin damage impairs human fertility. The Danish First Pregnancy Planner Study Team. Fertil. Steril. 73, 43-50 (2000). (Pubitemid 30018020)
27. Tesarik, J., Mendoza, C. & Greco, E. Paternal effects acting during the first cell cycle of human preimplantation development after ICSI. Hum. Reprod. 17, 184-189 (2002). (Pubitemid 34130284)
28. Aitken, R. J., Baker, M. A. & Sawyer, D. Oxidative stress in the male germ line and its role in the aetiology of male infertility and genetic disease. Reprod. Biomed. Online 7, 65-70 (2003). (Pubitemid 36874408)
29. Smit, M. et al. Decreased sperm DNA fragmentation after surgical varicocelectomy is associated with increased pregnancy rate. J. Urol. 183, 270-274 (2010).
30. Smith, R. et al. Increased sperm DNA damage in patients with varicocele: relationship with seminal oxidative stress. Hum. Reprod. 21, 986-993 (2006).
31. Greco, E. et al. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J. Androl. 26, 349-353 (2005). (Pubitemid 40628971)
32. Ackerman, S., McGuire, G., Fulgham, D. L. & Alexander, N. J. An evaluation of a commercially available assay for the detection of antisperm antibodies. Fertil. Steril. 49, 732-734 (1988).
33. Heidenreich, A., Bonfig, R., Wilbert, D. M., Strohmaier, W. L. & Engelmann, U. H. Risk factors for antisperm antibodies in infertile men. Am. J. Reprod. Immunol. 31, 69-76 (1994). (Pubitemid 24149350)
34. Collins, J. A., Burrows, E. A., Yeo, J. & YoungLai, E. V. Frequency and predictive value of antisperm antibodies among infertile couples. Hum. Reprod. 8, 592-598 (1993). (Pubitemid 23116965)
35. Jeyendran, R. S., Van der ven, H. H., Perez-Pelaez, M., Crabo, B. G. & Zaneveld, L. J. Development of an assay to assess the functional integrity of the human sperm membrane and its relationship to other semen characteristics. J. Reprod. Fertil. 70, 219-228 (1984). (Pubitemid 14223140)
36. Kallajoki, M., Virtanen, I. & Suominen, J. The fate of acrosomal staining during the acrosome reaction of human spermatozoa as revealed by a monoclonal antibody and PNA-lectin. Int. J. Androl. 9, 181-194 (1986). (Pubitemid 17210055)
37. Burkman, L. J. et al. The hemizona assay (HZA): development of a diagnostic test for the binding of human spermatozoa to the human hemizona pellucida to predict fertilization potential. Fertil. Steril. 49, 688-697 (1988).
38. Yanagimachi, R., Yanagimachi, H. & Rogers, B. J. The use of zona-free animal ova as a test-system for the assessment of the fertilizing capacity of human spermatozoa. Biol. Reprod. 15, 471-476 (1976).
39. Johnson, A., Bassham, B., Lipshultz, L. I. & Lamb, D. J. A quality control system for the optimized sperm penetration assay. Fertil. Steril. 64, 832-837 (1995).
40. O'Flynn O'Brien, K. L., Varghese, A. C. & Agarwal, A. The genetic causes of male factor infertility: a review. Fertil. Steril. 93, 1-12 (2010).
41. Ferlin, A. et al. Male infertility: role of genetic background. Reprod. Biomed. Online 14, 734-745 (2007). (Pubitemid 46951709)
42. Foresta, C., Ferlin, A., Gianaroli, L. & Dallapiccola, B. Guidelines for the appropriate use of genetic tests in infertile couples. Eur. J. Hum. Genet. 10, 303-312 (2002). (Pubitemid 34778049)
43. Kuroda-Kawaguchi, T. et al. The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat. Genet. 29, 279-286 (2001). (Pubitemid 33096452)
44. Hopps, C. V. et al. Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions. Hum. Reprod. 18, 1660-1665 (2003). (Pubitemid 36958046)
45. Egozcue, S. et al. Human male infertility: chromosome anomalies, meiotic disorders, abnormal spermatozoa and recurrent abortion. Hum. Reprod. Update 6, 93-105 (2000). (Pubitemid 30099347)
46. Egozcue, J., Blanco, J. & Vidal, F. Chromosome studies in human sperm nuclei using fluorescence in situ hybridization (FISH). Hum. Reprod. Update 3, 441-452 (1997). (Pubitemid 28069950)
47. Vegetti, W. et al. Correlation between semen parameters and sperm aneuploidy rates investigated by fluorescence in-situ hybridization in infertile men. Hum. Reprod. 15, 351-365 (2000). (Pubitemid 30076716)
48. Huang, W. J. et al. Germ-cell nondisjunction in testes biopsies of men with idiopathic infertility. Am. J. Hum. Genet. 64, 1638-1645 (1999). (Pubitemid 30481515)
49. Aitken, R. J. Whither must spermatozoa wander? The future of laboratory seminology. Asian J. Androl. 12, 99-103 (2010).
50. Haidl, G. Management strategies for male factor infertility. Drugs 62, 1741-1753 (2002). (Pubitemid 34948173)
51. Derosa, M. et al. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine. Eur. J. Endocrinol. 138, 286-293 (1998).
52. Coviello, A. D. et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J. Clin. Endocrinol. Metab. 90, 2595-2602 (2005). (Pubitemid 40686296)
53. Attia, A. M., Al-Inany, H. G. & Proctor, M. L. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD005071. doi:10.1002/14651858.CD005071.pub3 (2006).
54. Filippi, S. et al. Identification, localization and functional activity of oxytocin receptors in epididymis. Mol. Cell. Endocrinol. 193, 89-100 (2002). (Pubitemid 34823612)
55. Nicholson, H. D., Guldenaar, S. E., Boer, G. J. & Pickering, B. T. Testicular oxytocin: effects of intratesticular oxytocin in the rat. J. Endocrinol. 130, 231-238 (1991).
56. Byrne, M. M., Rolf, C., Depenbusch, M., Cooper, T. G. & Nieschlag, E. Lack of effect of a single I.V. Dose of oxytocin on sperm output in severely oligozoospermic men. Hum. Reprod. 18, 2098-2102 (2003). (Pubitemid 37265073)
57. Abel, B. J. et al. Randomised trial of clomiphene citrate treatment and vitamin C for male infertility. Br. J. Urol. 54, 780-784 (1982). (Pubitemid 13179623)
58. [No authors listed] A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. World Health Organization. Int. J. Androl. 15, 299-307 (1992).
59. Sokol, R. Z., Steiner, B. S., Bustillo, M., Petersen, G. & Swerdloff, R. S. A controlled comparison of the efficacy of clomiphene citrate in male infertility. Fertil. Steril. 49, 865-870 (1988).
60. Wang, C., Chan, C. W., Wong, K. K. & Yeung, K. K. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil. Steril. 40, 358-365 (1983). (Pubitemid 13000574)
61. Ronnberg, L. The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: a controlled double-blind cross-over study. Int. J. Androl. 3, 479-486 (1980). (Pubitemid 11225245)
62. Micic, S. & Dotlic, R. Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men. J. Urol. 133, 221-222 (1985). (Pubitemid 15158411)
63. Liu, P. Y. & Handelsman, D. J. The present and future state of hormonal treatment for male infertility. Hum. Reprod. Update 9, 9-23 (2003). (Pubitemid 36305580)
64. Hussein, A., Ozgok, Y., Ross, L. & Niederberger, C. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J. Androl. 26, 787-793 (2005).
65. Vandekerckhove, P., Lilford, R., Vail, A. & Hughes, E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD000151. doi:10.1002/14651858. CD000151 (1996).
66. Adamopoulos, D. A. et al. Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia. Fertil. Steril. 80, 914-920 (2003). (Pubitemid 37230027)
67. Raman, J. D. & Schlegel, P. N. Aromatase inhibitors for male infertility. J. Urol. 167, 624-629 (2002). (Pubitemid 34074542)
68. Pavlovich, C. P., King, P., Goldstein, M. & Schlegel, P. N. Evidence of a treatable endocrinopathy in infertile men. J. Urol. 165, 837-841 (2001). (Pubitemid 32156291)
69. Clark, R. V. & Sherins, R. J. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. J. Androl. 10, 240-247 (1989). (Pubitemid 19163597)
70. Eskenazi, B. et al. Antioxidant intake is associated with semen quality in healthy men. Hum. Reprod. 20, 1006-1012 (2005). (Pubitemid 40667848)
71. Buettner, G. R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300, 535-543 (1993). (Pubitemid 23232908)
72. Dawson, E. B., Harris, W. A., Teter, M. C. & Powell, L. C. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil. Steril. 58, 1034-1039 (1992).
73. Kessopoulou, E. et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin e to treat reactive oxygen species associated male infertility. Fertil. Steril. 64, 825-831 (1995).
74. Keskes-Ammar, L. et al. Sperm oxidative stress and the effect of an oral vitamin e and selenium supplement on semen quality in infertile men. Arch. Androl. 49, 83-94 (2003). (Pubitemid 36269762)
75. Rolf, C., Cooper, T. G., Yeung, C. H. & Nieschlag, E. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin e: a randomized, placebo-controlled, double-blind study. Hum. Reprod. 14, 1028-1033 (1999). (Pubitemid 29176484)
76. Lewin, A. & Lavon, H. The effect of coenzyme Q10 on sperm motility and function. Mol. Aspects Med. 18 (Suppl.), S213-S219 (1997).
77. Lenzi, A., Gandini, L. & Picardo, M. A rationale for glutathione therapy. Hum. Reprod. 13, 1419-1422 (1998). (Pubitemid 28310465)
78. Lloyd, D. R., Carmichael, P. L. & Phillips, D. H. Comparison of the formation of 8-hydroxy-2'-deoxyguanosine and single-and double-strand breaks in DNA mediated by fenton reactions. Chem. Res. Toxicol. 11, 420-427 (1998). (Pubitemid 28242486)
79. Iwanier, K. & Zachara, B. A. Selenium supplementation enhances the element concentration in blood and seminal fluid but does not change the spermatozoal quality characteristics in subfertile men. J. Androl. 16, 441-447 (1995).
80. Comhaire, F. H., El Garem, Y., Mahmoud, A., Eertmans, F. & Schoonjans, F. Combined conventional/antioxidant "Astaxanthin" treatment for male infertility: a double blind, randomized trial. Asian J. Androl. 7, 257-262 (2005). (Pubitemid 41288547)
81. Hinton, B. T., Snoswell, A. M. & Setchell, B. P. The concentration of carnitine in the luminal fluid of the testis and epididymis of the rat and some other mammals. J. Reprod. Fertil. 56, 105-111 (1979).
82. Matalliotakis, I. et al. L-Carnitine levels in the seminal plasma of fertile and infertile men: correlation with sperm quality. Int. J. Fertil. Womens Med. 45, 236-240 (2000). (Pubitemid 30470182)
83. Lenzi, A. et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil. Steril. 79, 292-300 (2003). (Pubitemid 36144052)
84. Lenzi, A. et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil. Steril. 81, 1578-1584 (2004). (Pubitemid 38749002)
85. Costa, M., Canale, D., Filicori, M., D'Lddio, S. & Lenzi, A. L-Carnitine in idiopathic asthenozoospermia: a multicenter study. Italian Study Group on Carnitine and Male Infertility. Andrologia 26, 155-159 (1994).
86. Sigman, M., Glass, S., Campagnone, J. & Pryor, J. L. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil. Steril. 85, 1409-1414 (2006).
87. Brinster, R. L. & Avarbock, M. R. Germline transmission of donor haplotype following spermatogonial transplantation. Proc. Natl Acad. Sci. USA 91, 11303-11307 (1994). (Pubitemid 24356332)
88. Sadri-Ardekani, H. et al. Propagation of human spermatogonial stem cells in vitro. JAMA 302, 2127-2134 (2009).
89. Goossens, E., Frederickx, V., De Block, G., Van Steirteghem, A. C. & Tournaye, H. Reproductive capacity of sperm obtained after germ cell transplantation in a mouse model. Hum. Reprod. 18, 1874-1880 (2003). (Pubitemid 37107561)
90. Fujita, K. et al. Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J. Clin. Invest. 115, 1855-1861 (2005). (Pubitemid 40979724)
91. Fujita, K. et al. Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy. Cancer Res. 66, 11166-11171 (2006). (Pubitemid 46009943)
92. Geens, M. et al. The efficiency of magnetic-activated cell sorting and fluorescence-activated cell sorting in the decontamination of testicular cell suspensions in cancer patients. Hum. Reprod. 22, 733-742 (2007).
93. Smith, K. R. Gene therapy: theoretical and bioethical concepts. Arch. Med. Res. 34, 247-268 (2003). (Pubitemid 37080579)
94. Kojima, Y., Kohri, K. Therapeutic options: current research and future prospects for gene therapy in andrology 592-598 (Springer, Heiderberg, 2006).
95. Yomogida, K., Yagura, Y. & Nishimune, Y. Electroporated transgene-rescued spermatogenesis in infertile mutant mice with a sertoli cell defect. Biol. Reprod. 67, 712-717 (2002). (Pubitemid 34925186)
96. Kruger, T. F. et al. Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil. Steril. 46, 1118-1123 (1986). (Pubitemid 17215837)
97. Amelar, R. D., Dubin, L. & Schoenfeld, C. Semen analysis. An office technique. Urology 2, 605-611 (1973).